The global tissue sectioning market is anticipated to expand at substantial CAGR during the forecast period, between 2020 and 2027. Increasing awareness among the general population regarding chronic diseases is driving the demand for tissue sectioning products.
Tissue sectioning is a technique which is used for cutting the tissues in thin slices to determine and identify the abnormalities in the tissues. This technique is used for the detection of breast nodules, which are used for the mastectomy and for the treatment of congenital megacolon in children and neonates.
The report on the global tissue sectioning market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Attributes |
Details |
Base Year |
2019 |
Historic Data |
2017 & 2018 |
Forecast Period |
2020–2027 |
Regional Scope |
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
Report Coverage |
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast |
In the terms of products, the tissue sectioning market has been segmented into instruments, accessories & consumables, and services. The instruments segment is sub-segmented into rotary microtome, sliding microtome, ultramicrotome, cryostat, and others. The microtome segment is projected to grow at a significant pace during the forecast period due to rising awareness regarding the advantages of using rotary microtome. Rotary microtomes are used for cutting hard, soft, and fatty tissues into thin slices.
Based on technology, the market is fragmented into automatic, semi-automatic, and manual. The automatic segment holds a considerable share of the market and is projected to expand at a rapid pace during the forecast period. The growth of the segment is attributed to several benefits associated to the using of automatic technology such as high section scalability and reliability.
On the basis of applications, the tissue sectioning market has been segregated into research and diagnosis. The diagnosis segment is expected to hold a significant market share during the forecast period. Rising prevalence of cancer has led to the rise in the use of tissue sectioning for the biopsy of diseases. Tissue sectioning is used in medical research for the analysis of drug molecules.
In terms of end-users, the market is classified as hospitals, clinics, diagnostic laboratories, and research centers. The hospitals segment holds a significant share of the market due to the rise in the demand for the analysis of specimens for histopathology and cytopathology and growing number of cancer patients in hospitals.
Based on regions, the global tissue sectioning market is categorized as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounts for a considerable share of the global tissue sectioning market. The market is expected to develop significantly in the US during the forecast period due to strong R&D, increasing investments by public and private sectors in tissue diagnostics, and rapid adoption of technologically advanced products.
Key players in the global tissue sectioning market include Thermo Fisher Scientific, Sakura Finetek, Danaher Corporation, MEDITE GmbH, SLEE Medical GmbH, Histo-Line Laboratories, RMC Boeckeler, Jinhua YIDI Medical Appliance, Diapath S.p.A., and Amos Scientific. Mergers & acquisitions, collaborations, agreements, and partnerships are some growth strategies adopted by these players to strengthen their geographical presence.
Some other reports from this category!